OIG flags organ acquisition reimbursement and documentation risks
Oct 4, 2026 edition · GC-2026-0024 · Published 2026-10-04 · Version 2 · Announced
OIG estimated $380 million for organ-acquisition costs outside Medicare-covered transplants and separately recommended recovering $154,210 for undocumented organ counts.
What happened
OIG's organ-acquisition audit, issued September 1 and posted September 3, 2026, reviewed costs reported for 2017–2022. Of 180 sampled organs reported as Medicare usable,43 were not used in Medicare-covered transplants and 12 were never transplanted. Medicare reimbursed $2.8 million for those 55 organs. OIG estimated about $380 million across the six-year period and identified a conflict between CMS guidance and the statutory limit on reimbursement for organs used in Medicare-covered transplants. The estimate does not assign an organization-specific liability or direct blanket recovery of $380 million.
The guidance assumed that organs removed and furnished to an organ-procurement organization or another transplant center would be used for a Medicare transplant, which did not always occur. Separately, two centers lacked documentation for five reported organs, producing $154,210 in unallowable reimbursement. OIG recommended MAC recovery of that amount and revision of the organ-counting guidance to align with the statute. CMS concurred with recovery, but did not specifically concur or nonconcur with the guidance recommendation. Documentation recovery and the broader policy conflict are therefore distinct findings requiring different follow-up.
Scope and timing
- Authority status
- Announced
- Applicability
- Operationally relevant
- Audience
- Health systems, Provider networks
- Jurisdiction
- Federal
- Affected functions
- Finance, Clinical Operations, Compliance, Legal
- Responsible owner
- Finance
Why it matters
Organ disposition and supporting records need to reconcile to cost-report counts, while guidance conflicts require legal and MAC review rather than an assumed blanket recoupment.
Recommended action
Trace organ counts to disposition and documentation, assess the guidance conflict with counsel and monitor MAC instructions. Evaluate actual organization-specific exposure before treating the estimate as a payable balance.
Sources
- Organ acquisition reimbursement auditOfficial · HHS OIG · 2026-09-03 · Source review 2026-09-06
Complete edition and supplemental material
This finding in the complete approved report →Regulatory horizons, CIA trends and implementation trackers remain in the full report.
Read the entire Medicare & Medicaid report →